| PRODUCT | Co has more than 80 APIs in its generics portfolio and is committed to adding six to eight more per year. At the same time, it has an exclusive synthesis business, although on a smaller scale. |
| SALES VALUE | Sales of generic APIs in 2001 were about $114 million, or 23% of total revenues, while exclusive APIs contributed about $61 million, 12% of total revenues |
| UPDATE | 09.02 |
| COMPANY | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |